| Date Checked | 2026-02-19 22:12:20 |
|---|---|
| Graham Number | (PB)nan vs (PE)0.00 |
| Over / Under Value Percentage | 0.00% vs 0.00% |
| Dividend Yield | 0.00% |
| Dividend Date | None |
| Symbol | BEAM |
| AssetType | Common Stock |
| Name | Beam Therapeutics Inc |
| Description | Beam Therapeutics Inc. is an innovative biotechnology firm based in Cambridge, Massachusetts, at the forefront of precision genetic therapies targeting severe and life-threatening diseases. Utilizing its proprietary base editing technology, Beam aims to create groundbreaking treatments that address the root causes of genetic disorders, reshaping the landscape of genetic therapeutics. With a robust pipeline of novel therapies in development, the company is well-positioned to enhance patient outcomes and redefine therapeutic strategies. Beam Therapeutics is dedicated to addressing the intricate challenges faced by patients and healthcare providers as it advances its clinical programs in this dynamic field. |
| CIK | 1745999 |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | BIOTECHNOLOGY |
| Address | 238 MAIN STREET, CAMBRIDGE, MA, UNITED STATES, 02142 |
| OfficialSite | https://beamtx.com |
| FiscalYearEnd | December |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 3202549000 |
| EBITDA | -444216000 |
| PERatio | 0 |
| PEGRatio | None |
| BookValue | 9.8 |
| DividendPerShare | None |
| EPS | -4.41 |
| RevenuePerShareTTM | 0.593 |
| ProfitMargin | 0 |
| OperatingMarginTTM | -13.08 |
| ReturnOnAssetsTTM | -0.235 |
| ReturnOnEquityTTM | -0.472 |
| RevenueTTM | 55701000 |
| GrossProfitTTM | -356086016 |
| DilutedEPSTTM | -4.41 |
| QuarterlyEarningsGrowthYOY | 0 |
| QuarterlyRevenueGrowthYOY | -0.32 |
| AnalystTargetPrice | 45.47 |
| AnalystRatingStrongBuy | 1 |
| AnalystRatingBuy | 13 |
| AnalystRatingHold | 2 |
| AnalystRatingSell | 0 |
| AnalystRatingStrongSell | 0 |
| TrailingPE | - |
| ForwardPE | - |
| PriceToSalesRatioTTM | 57.5 |
| PriceToBookRatio | 3.315 |
| EVToRevenue | 40.91 |
| EVToEBITDA | -7.03 |
| Beta | 2.073 |
| 52WeekHigh | 36.44 |
| 52WeekLow | 13.53 |
| 50DayMovingAverage | 26.98 |
| 200DayMovingAverage | 21.82 |
| SharesOutstanding | 101475000 |
| SharesFloat | 87410000 |
| PercentInsiders | 1.239 |
| PercentInstitutions | 101.921 |
| ExDividendDate | None |
| naga | 0 |
| etoro | 0 |
| dateChecked | 2026-02-19 22:12:20 |
| fresh | 1 |